add

Singapore (Feb 21): CIMB is maintaining its “add” call on Sembcorp Industries (SCI) with an unchanged target price of $3.87 after the conglomerate on Monday said it was reorganising its India energy operations for a more streamlined shareholding struc

SINGAPORE (Feb 13): UOB Kay Hian is maintaining its “buy” recommendation on ISOTeam on expectations the group should see a catchup in revenue in 2H18.

SINGAPORE (Feb 13): CIMB is reiterating its “add” call on Valuetronics Holdings with an unchanged target price of $1.10, which is pegged to 11 times CY19 forward earnings and implies 4% FY18-20 dividend yield, after the tech manufacturer last Friday p

SINGAPORE (Feb 2): CIMB Research is maintaining its “add” call on GuocoLand while raising its target price to $2.88 from $2.82 previously, after tweaking RNAV projections post the property developer’s 2Q18 financial results.

SINGAPORE (Jan 18): CIMB Research is maintaining its “add” call on ESR-REIT while raising its target price on the trust to 64 cents from 63 cents previously on lower cost of equity of 8.1% from 8.5% previously.  

SINGAPORE (Nov 27): Brokerages are unanimously positive on Thai Beverage (ThaiBev) after the F&B group last week reported a surge in FY17 earnings on the back of fair value gains by Singapore-based Fraser & Neave (F&N), coming in line with general expecta

SINGAPORE (Nov 14): CIMB is maintaining its “add” call on Aspen (Group) Holdings with an unchanged target price of 29 cents, based on a 45% discount to RNAV of 53 cents after leaving FY17-19F earnings estimates unchanged.

SINGAPORE (Nov 13): CIMB Research is maintaining its “add” call on UMS Holdings while raising its target price to $1.21 from $1.13, as it increases its P/BV multiple to 2.88 times versus 2.8 times previously on higher ROEs.

SINGAPORE (Nov 13): CIMB Research continues to rate Jadason Enterprises at “add” with a lower target price of 11 cents after rolling over its valuation basis to FY19F estimates, still based on 12.34 times P/E – which is 2 s.d. above the average forw

SINGAPORE (Sept 18): CIMB Research is upgrading its call on Raffles Medical Group (RMG) to “add” from “reduce” with a lower price target of $1.21 from $1.25 previously on the belief that the stock is looking attractive to gain exposure to the grow